This project has been flagged by a community member as inappropriate due to reason below.*

Expert Interview

Slingshot members are talking to an expert! The topic is:

Examining Medtronic’s newly FDA-approved Altaviva™ implantable tibial neuromodulation device in managing urge urinary incontinence

Ticker(s): MDT

Who's the expert?

Institution: Steinberg Urology

  • Board-certified minimally-invasive urologist practicing at Steinberg urology, private urological care.
  • Currently manages ~90 patients with NMIBC.
  • Supported the development of minimally invasive therapies like UroLift, Rezum, Aquablation, iTind

Interview Goal
This call will focus on discussing Altaviva, an implantable tibial neuromodulation device that was approved by the FDA to manage urge urinary incontinence

Are You Interested In These Questions?

Slingshot Insights Explained

Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.

Reason

*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.